Recent Finacing
Recent Raise
Gallant develops off-the-shelf uterine-derived allogeneic mesenchymal stem-cell therapies for dogs and cats, operates spay/neuter collection and lifetime banking, and advances clinical-stage products for FCGS, osteoarthritis, dermatitis.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
